Related references
Note: Only part of the references are listed.GnRH agonist triggering: recent developments
Shahar Kol et al.
REPRODUCTIVE BIOMEDICINE ONLINE (2013)
Comparison of cabergoline and intravenous albumin in the prevention of ovarian hyperstimulation syndrome: a randomized clinical trial
Ensieh Shahrokh Tehraninejad et al.
JOURNAL OF ASSISTED REPRODUCTION AND GENETICS (2012)
Administration of Intravenous Albumin around the Time of Oocyte Retrieval Reduces Pregnancy Rate without Preventing Ovarian Hyperstimulation Syndrome: A Systematic Review and Meta-Analysis
Byung Chul Jee et al.
GYNECOLOGIC AND OBSTETRIC INVESTIGATION (2010)
Can dopamine agonists reduce the incidence and severity of OHSS in IVF/ICSI treatment cycles? A systematic review and meta-analysis
Mohamed A. F. M. Youssef et al.
HUMAN REPRODUCTION UPDATE (2010)
Gonadotropin-Releasing Hormone Agonist Trigger: The Way to Eliminate Ovarian Hyperstimulation Syndrome - A 20-Year Experience
Shahar Kol et al.
SEMINARS IN REPRODUCTIVE MEDICINE (2010)
Physiology and Pathology of Ovarian Hyperstimulation Syndrome
Raul Gomez et al.
SEMINARS IN REPRODUCTIVE MEDICINE (2010)
Cabergoline reduces the early onset of ovarian hyperstimulation syndrome: a prospective randomized study
Carlos Carizza et al.
REPRODUCTIVE BIOMEDICINE ONLINE (2008)
The ISMAAR proposal on terminology for ovarian stimulation for IVF
G. Nargund et al.
HUMAN REPRODUCTION (2007)
Milder ovarian stimulation for in-vitro fertilization reduces aneuploidy in the human preimplantation embryo:: a randomized controlled trial
Esther B. Baart et al.
HUMAN REPRODUCTION (2007)
The early luteal phase administration of estrogen and progesterone does not induce premature luteolysis in normo-ovulatory women
Nicole G. M. Beckers et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2006)
The science behind 25 years of ovarian stimulation for in vitro fertilization
NS Macklon et al.
ENDOCRINE REVIEWS (2006)
Comparison of GnRH agonists and antagonists in assisted reproduction cycles of patients at high risk of ovarian hyperstimulation syndrome
G Ragni et al.
HUMAN REPRODUCTION (2005)
Preterm birth and low birth weight after assisted reproductive technology-related pregnancy in Australia between 1996 and 2000
YA Wang et al.
FERTILITY AND STERILITY (2005)
The effects of 'coasting' on follicular fluid concentrations of vascular endothelial growth factor in women at risk of developing ovarian hyperstimulation syndrome
AJ Tozer et al.
HUMAN REPRODUCTION (2004)
Reproductive biology and IVF: ovarian stimulation and endometrial receptivity
P Devroey et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2004)
Comoarison of coastina and intravenous albumin in the prevention of ovarian hyperstimulation syndrome
CD Chen et al.
FERTILITY AND STERILITY (2003)
Intravenous albumin for preventing severe ovarian hyperstimulation syndrome: a Cochrane review
M Aboulghar et al.
HUMAN REPRODUCTION (2002)
The significance of coasting duration during ovarian stimulation for conception in assisted fertilization cycles
U Ulug et al.
HUMAN REPRODUCTION (2002)
A low-dose stimulation protocol using highly purified follicle-stimulating hormone can lead to high pregnancy rates in in vitro fertilization patients with polycystic ovaries who are at risk of a high ovarian response to gonadotropins
R Marci et al.
FERTILITY AND STERILITY (2001)
Dose-finding study of triptorelin acetate for prevention of a premature LH surge in IVF: a prospective, randomized, double-blind, placebo-controlled study
RMJ Janssens et al.
HUMAN REPRODUCTION (2000)
Increased risk of early pregnancy loss by profound suppression of luteinizing hormone during ovarian stimulation in normogonadotrophic women undergoing assisted reproduction
LG Westergaard et al.
HUMAN REPRODUCTION (2000)
An ounce of prevention: outpatient management of the ovarian hyperstimulation syndrome
MR Fluker et al.
FERTILITY AND STERILITY (2000)
Share Paper
